Biotech Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results October 31, 2025
Biotech NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem’s Shares October 30, 2025
Biotech NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem October 29, 2025
Biotech Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets October 28, 2025
Biotech Published in The Lancet: Nipocalimab significantly decreased Sjögren’s disease (SjD) activity and severity through substantial reduction in Sjögren’s-related autoantibodies October 27, 2025
Biotech BioLab Holdings, Inc. Announces Investment in Cold Atmospheric Plasma Technology October 25, 2025
Biotech FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease October 24, 2025
Biotech NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 October 23, 2025
Search
Biotech
November 1, 2025
October 31, 2025
October 30, 2025
October 29, 2025
October 28, 2025
October 27, 2025
October 26, 2025
October 25, 2025
October 24, 2025
October 23, 2025
